Clinical Trials Logo

Filter by:
NCT ID: NCT00841620 Completed - Hemorrhoids Clinical Trials

Symptom Control 1-year After Circular Stapler Anopexy or Diathermy Excision for Prolapsed Haemorhoids

Start date: September 1999
Phase: Phase 4
Study type: Interventional

Background: In an international randomised controlled trial we studied how patient self-reported symptoms improved after either a stapled anopexy operation or a diathermy excision of the haemorrhoids. Methods: The study involved 18 hospitals in Sweden, Denmark and the UK. Two hundred and seven patients were randomised. After exclusion of 27 patients, 90 in both groups were operated and followed one year. Patients provided self-reported symptoms before surgery and after 1 year. A patient diary obtained daily self-reported postoperative pain scores (VAS). Surgeons evaluated the anal anatomy before surgery and after 1 year.

NCT ID: NCT00839826 Completed - Thromboembolism Clinical Trials

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

ODiXaHip
Start date: December 2002
Phase: Phase 2
Study type: Interventional

Patients undergoing surgery, especially hip and knee surgery, are at high risk for VTE (up to 60 % without prophylaxis). The administration of drugs for thromboprophylaxis, such as heparins, significantly lowers that risk, but heparins have to be applied below the skin (subcutaneously). Additionally, there is a chance of developing a heparin-induced thrombocytopenia (decrease in platelets). Therefore, there is still a need for new agents which are safer and more efficient and which are easier to apply.The purpose of this study is to compare the safety and efficacy of BAY 59-7939 with the safety and efficacy of the licensed drug Enoxaparin. Enoxaparin, a so-called low molecular heparin, is approved and widely used in the area of thromboprophylaxis and will be given once daily subcutaneously.Another important purpose of the study is to find the optimal dose of BAY 59-7939 for thromboprophylaxis after hip replacement surgery. Therefore, there are several dose steps planned.

NCT ID: NCT00839735 Completed - Asthma Clinical Trials

Trefoil Peptides in Lung Diseases

Start date: February 2009
Phase:
Study type: Observational

The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.

NCT ID: NCT00836420 Completed - Clinical trials for Fulminant Hepatic Failure

Cerebral Microdialysis in Patients With Fulminant Hepatic Failure

Start date: January 2000
Phase: N/A
Study type: Observational

Patients with fulminant hepatic failure (FHF) often develop cerebral edema, high intracranial pressure (ICP)that may result in fatal brain damage. The aim in this protocol is to determine if a rise in the brain concentration of glutamate, lactate and pyruvate are involved in development of surges of high ICP in patients with FHF. The study is observatory in nature and also record the influence of any intervention that may e instituted during the course of the critical illness.

NCT ID: NCT00835848 Completed - Clinical trials for Myocardial Infarction

Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI

POSTCON II
Start date: January 2009
Phase: Phase 4
Study type: Interventional

Both pre- and postconditioning seem to protect cardiomyocytes during reperfusion therapy. Investigations both ex vivo and in vivo suggest that a gut derived hormone, Glucagon-Like-Peptide-1 (GLP-1), is able to reduce reperfusioninjury after myocardial ischemia. Results from our own laboratory have shown a marked reduction in infarct size when rat hearts in a Langendorf preparation were exposed to the GLP-1 analogue, exendin-4. The investigators want to investigate to what extent this effect can be translated to humans in the setting of acute STEMI treated with primary PCI when evalutaed by cardiac magnetic resonance imaging.

NCT ID: NCT00835003 Completed - Clinical trials for Respiratory Disorders

Timing of Planned Caesarean Section and Morbidity of the Newborn

Start date: March 2009
Phase: N/A
Study type: Interventional

The caesarean section rate is rising globally. About 10% of the newborns are submitted to a neonatal department after planned caesarean section, primarily with respiratory disorders. More children are submitted if caesarean is performed earlier in pregnancy. Study hypothesis: More newborns are admitted after planned caesarean at 38 weeks and 3 days of gestation than after 39 weeks and 3 days of gestation. Aim of study: To compare elective caesarean section performed at 38 weeks and 3 days of gestation with 39 weeks and 3 days of gestation. According to this timing to determine the proportion of newborns admitted within 48 hours after birth.

NCT ID: NCT00834548 Completed - Atherosclerosis Clinical Trials

Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols

Start date: June 2008
Phase: N/A
Study type: Observational

To compare to different approaches in whole-body magnetic resonance angiography of patients suffering peripheral arterial disease. Our hypothesis is that use of a new protocol improves the diagnostic quality of the WB-MRA procedure.

NCT ID: NCT00832741 Completed - Type 1 Diabetes Clinical Trials

Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

Start date: May 2008
Phase: N/A
Study type: Observational

The purpose of this study is to investigate whether secretion of incretin hormones is intact and to what extent endogenous as well as exogenous GLP-1 controls postprandial glucose excursions in patients with type-1 diabetes mellitus.

NCT ID: NCT00832663 Completed - Muscle Damage Clinical Trials

Influence of Non-steroidal Anti-inflammatory Drugs (NSAID) on Muscle Regeneration

Start date: April 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the influence of non-steroidal anti-inflammatory drugs (NSAIDs) on muscle regeneration. The investigators' hypothesis is that ingestion of NSAID will delay or impair muscle regeneration.

NCT ID: NCT00832078 Completed - Healthy Clinical Trials

Test Catheter Pilot Study in Healthy Volunteers

Test catheter
Start date: January 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety of an intermittent catheter in comparison with an already existing catheter on the market. The study is a randomised, single blinded, cross-over study including 25 healthy males.